Clinical Trials

Oral food challenge

Displaying 3 studies

A Study to Evaluate the Safety and Effectiveness of Dupilumab and Milk Oral Immunotherapy to Treat Patients with Cow's Milk Allergy Scottsdale/Phoenix, AZ

The purpose of this study is to assess whether dupilumab as an adjunct to milk oral immunotherapy (OIT) compared to placebo improves desensitization and safety, defined as an increase in the proportion of subjects who pass a double-blind placebocontrolled food challenge (DBPCFC) to at least 2040 mg cumulative milk protein at week 18.
Dose-Ranging Study Of The Efficacy And Safety Of TAK-101 For Prevention Of Gluten-Specific T Cell Activation In Participants With Celiac Disease On A Gluten-Free Diet Rochester, MN

The purpose of this study is to compare the number of baseline interferon-gamma (IFN-γ) spot forming units (SFUs) to the number of IFN-γ SFUs after a 6-day oral gluten challenge among HLA DQ2–positive subjects treated with TAK-101 versus placebo.
Study Evaluating The Safety And Efficacy Of Neffy Or Intramuscular Adrenalin In Patients With Allergic Reactions After Oral Food Challenge Or Allergen Immunotherapy Austin, MN; Rochester, MN
The study is to assess the safety of neffy or IM Adrenalin in patients who are experiencing allergic reactions after an OFC, allergen Immunotherapy (AIT), or other allergy challenge that may require epinephrine intervention.